Johnson & Johnson Pre-Tax Income 2010-2024 | JNJ

Johnson & Johnson pre-tax income for the twelve months ending June 30, 2024 was $19.505B, a 53.87% increase year-over-year.

  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
  • Johnson & Johnson annual pre-tax income for 2022 was $19.359B, a 0.94% increase from 2021.
  • Johnson & Johnson annual pre-tax income for 2021 was $19.178B, a 16.25% increase from 2020.

Johnson & Johnson Pre-Tax Income 2010-2024 | JNJ

  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
  • Johnson & Johnson annual pre-tax income for 2022 was $19.359B, a 0.94% increase from 2021.
  • Johnson & Johnson annual pre-tax income for 2021 was $19.178B, a 16.25% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B